Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice

International Immunopharmacology

Volumn 15, Issue 2, 2013, Pages 433-441

  Hyam, Supriya R ^a   Jang, Se Eun ^a   Jeong, Jin Ju ^a   Joh, Eun Ha ^a   Han, Myung Joo ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Colitis; Condonopsis lanceolata; Echinocystic acid; Inflammation; Lancemaside A; NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; ECHINOCYSTIC ACID; ECHINOCYSTIC ACID 3 O BETA D GLUCOPYRA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LANCEMASIDE A; LANCEMASIDE X; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PLANT EXTRACT; PROTEIN P56; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CODONOPSIS; CODONOPSIS LANCEOLATA; COLITIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CODONOPSIS; COLITIS; COLON; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED ICR; NF-KAPPA B; OLEANOLIC ACID; PROTEIN BINDING; RHIZOME; SAPONINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID;

EID: 84873470011     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.12.017     Document Type: Article

References (25)

1. V. Binder Epidemiology of IBD during the twentieth century: an integrated view Best Pract Res Clin Gastroenterol 18 2004 463 479
2. F. Shanahan Crohn's disease Lancet 359 2002 62 69
3. F. Rafii, R. van Embdin, and L.M.C. van Lieshout Changes in bacterial enzymes and PCR profiles of fecal bacteria from a patient with ulcerative colitis before and after antimicrobial treatments Dig Dis Sci 44 1999 637 642
4. R. Atreya, J. Multer, S. Fintoo, J. Müllberg, T. Jostock, and S. Wirtz Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nat Med 6 2000 583 588
5. F. Peris-Bondia, A. Latorre, A. Artacho, A. Moya, and G. D'Auria The active human gut microbiota differs from the total microbiota PLoS One 6 2011 e22448
6. S. Pendyala, J.M. Walker, and P.R. Holt A high-fat diet is associated with endotoxemia that originates from the gut Gastroenterology 142 2012 1100 1101
7. S.A. Radema, S.J. van Deventer, and A. Cerami Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis Gastroenterology 100 1991 1180 1186
8. E. Cario, and D.K. Podolsky Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infect Immun 68 2000 7010 7017
9. H.C. Jung, I. Eckmann, S.K. Yang, A. Panja, J. Fierer, and E. Morzycka-Wroblewska A distinct array of proinflammatory cytokine is expressed in human colon epithelia cells in response to bacterial invasion J Clin Invest 95 1995 55 65
10. J.C. Chow, D.W. Young, D.T. Golenbock, W.J. Christ, and F. Gusovsky Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J Biol Chem 274 1999 10689 10692
11. M. Ushijima, N. Komoto, Y. Sugizono, I. Mizuno, M. Sumihiro, and M. Ichikawa Triterpene glycosides from the roots of Codonopsis lanceolata Chem Pharm Bull(Tokyo) 56 2008 308 314
12. E.H. Joh, and D.H. Kim Lancemaside A inhibits lipopolysaccharide-induced inflammation by targeting LPS/TLR4 complex J Cell Biochem 111 2010 865 871
13. E.H. Joh, I.A. Lee, S.J. Han, S. Chae, and D.H. Kim Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice Int J Colorectal Dis 25 2010 545 551
14. E.H. Joh, W. Gu, and D.H. Kim Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways Biochem Pharmacol 84 2012 331 340
15. E.H. Joh, and D.H. Kim A sensitive liquid chromatography-electrospray tandem mass spectrometric method for lancemaside A and its metabolites in plasma and a pharmacokinetic study in mice J Chromatogr B Analyt Technol Biomed Life Sci 878 2010 1875 1880
16. E.H. Joh, and D.H. Kim Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways Br J Pharmacol 162 2011 1731 1742
17. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
18. I.A. Lee, E.A. Bae, Y.J. Hyun, and D.H. Kim Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice J Inflamm 7 2010 7
19. R. Blanque, C. Meakin, S. Millet, and C.R. Gardner Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1 beta, IL6 and TNF alpha Gen Pharmacol 27 1996 973 977
20. R.R. Ingalls, H. Heine, E. Lien, A. Yoshimura, and D. Glenbock Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors Infect Dis Clin N Am 13 1999 341 353
21. A. Kotanidou, A. Xagorari, E. Bagli, P. Kitsanta, T. Fotsis, and A. Papapetropoulos Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice Am J Respir Crit Care Med 165 2002 818 823
22. Y.T. Huang, J.J. Hwang, P.P. Lee, F.C. Ke, J.H. Huang, and C.J. Huang Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor Br J Pharmacol 128 1999 999 1010
23. E.H. Joh, I.A. Lee, I.H. Jung, and D.H. Kim Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation Biochem Pharmacol 82 2011 278 286
24. I.A. Lee, Y.J. Hyun, and D.H. Kim Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation Eur J Pharmacol 648 2010 62 70
25. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, and K.K. Park Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutat Res 480-481 2001 243 268